A redesigned cancer immunotherapy is showing striking early results after decades of disappointment with similar drugs. Researchers engineered a more powerful CD40 agonist antibody and changed how it’s delivered—injecting it directly into tumors instead of into the bloodstream. In a small clinical trial of 12 patients with metastatic cancers, six saw their tumors shrink and two experienced complete remission.
source https://www.sciencedaily.com/releases/2026/03/260315225121.htm
Pharmaceuticals face 100% tariffs in US - unless firms strike a deal
-
The order does not affect generic medicines, the most commonly used in the
US.
source
https://www.bbc.com/news/articles/cx29kke01gpo?at_medium=RSS&at_camp...
17 hours ago
No comments:
Post a Comment